PT Bio Farma plans to start clinical trials of Sinovac Biotech's coronavirus vaccine next month and aims to begin commercial production early next year, Bloomberg reported on Tuesday.
CoronaVac will be administered to 1620 people aged 18 to 59 years, said PT Bio Farma president Director Honesti Basyir.
Bio Farma has secured 2400 doses of CoronaVac, and the trial is expected to be completed in six months, Basyir added.
Penny Lukito, chief of Indonesia's National Agency of Drug and Food Control, said that once the vaccine successfully clears the final phase of the clinical trials, its production and distribution can begin without any delay as the regulator is working on the licensing process.
To read more NewsPoints articles, click here.